Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,963 | 141,207 | 56,947 | 174,960 | 90,636 |
| Marketable Securities | 757,241 | 757,745 | 760,979 | 657,371 | 745,923 |
| TOTAL | $882,598 | $934,706 | $878,638 | $864,436 | $868,839 |
| Non-Current Assets | |||||
| PPE Net | 53,732 | 58,717 | 57,765 | 55,236 | 50,822 |
| Investments And Advances | 24,703 | 78,463 | 235,844 | 359,373 | 445,463 |
| Other Non-Current Assets | 94,588 | 94,355 | 99,096 | 95,135 | 88,889 |
| TOTAL | $173,023 | $231,535 | $392,705 | $509,744 | $585,174 |
| Total Assets | $1,055,621 | $1,166,241 | $1,271,343 | $1,374,180 | $1,454,013 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,745 | 10,844 | 8,458 | 11,137 | 9,594 |
| Accrued Expenses | 33,299 | 39,413 | 49,841 | 43,906 | 38,320 |
| Other current liabilities | 40,938 | 31,929 | 24,993 | 38,857 | 31,143 |
| TOTAL | $90,146 | $91,057 | $91,877 | $102,208 | $87,093 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 33,724 | 42,554 | 51,182 | 36,673 | 42,794 |
| TOTAL | $39,278 | $48,131 | $56,780 | $42,288 | $48,425 |
| Total Liabilities | $129,424 | $139,188 | $148,657 | $144,496 | $135,518 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,662 | 146,212 | 145,276 | 145,215 | 143,922 |
| Common Shares | 1,793 | 1,783 | 1,778 | 1,768 | 1,764 |
| Retained earnings | -1,922,975 | -1,796,073 | -1,671,954 | -1,538,984 | -1,424,231 |
| Other shareholders' equity | 1,101 | 939 | 2,037 | 2,020 | 5,529 |
| TOTAL | $926,197 | $1,027,053 | $1,122,686 | $1,229,684 | $1,318,495 |
| Total Liabilities And Equity | $1,055,621 | $1,166,241 | $1,271,343 | $1,374,180 | $1,454,013 |